Fingerprint
Dive into the research topics of 'Phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomas'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomas
Brian Schulte, Nisha Mohindra, Mohammed Milhem, Steven Attia, Steven Robinson, Varun Monga, Angela C. Hirbe, Peter Oppelt, John Charlson, Irene Helenowski, Susan Abbinanti, Rasima Cehic, Scott Okuno, Brian A. Van Tine, Mark Agulnik
- Section of Medical Oncology
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Institute of Clinical and Translational Sciences (ICTS)
- Neurofibromatosis (NF) Center
- Siteman Cancer Center
- DBBS - Molecular Cell Biology
- DBBS - Molecular Genetics and Genomics
- DBBS - Cancer Biology
- Brain Tumor Center
Research output: Contribution to journal › Article › peer-review
13
Scopus
citations